Document is current

Article History

Received: 6 January 2026

Accepted: 13 February 2026

First Online: 28 February 2026

Declarations

:

: Elisa Bentivegna, Alessia Catalisano, Greta Insalata, Rubina Girolamo R. G., Martina Marinato M. M., Luca Paita, Marzi C, Alessandra Sorano, and Clara De Filippis C. declare no conflicts of interest. Federico Lavorini received research grants from GlaxoSmithKline and Chiesi Farmaceutici (payments made to the institution) and honoraria for lectures from AstraZeneca, Chiesi Farmaceutici, GSK, MSD Italia, HIKMA, Menarini International in the past 36 months. Federico Lavorini is an Editorial Board member of Pulmonary and Therapy . Federico Lavorini was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Gianna Camiciottoli received research grants from AstraZeneca, GlaxoSmithKline, Sanofi, and Chiesi Farmaceutici; congress sponsorship from Chiesi Farmaceutici; and a payment from GlaxoSmithKline for chairing a session in the past 36 months. Chiara Allegrini has received research grants from Sanofi, AstraZeneca, and Chiesi Farmaceutici; and congress sponsorship from AstraZeneca in the past 36 months.

: This study used de-identified data from the SANI Registry (Severe Asthma Network in Italy). The SANI Registry protocol was approved by the relevant Ethics Committee(s) (coordinating center and participating sites, as applicable). All participants provided written informed consent for inclusion in the SANI Registry and for the use of their de-identified data for research purposes.